(Q37109907)

18 August 2017

1 reference

title

Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders (English)

1 reference

18 August 2017

1 reference

0 references

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

5 December 2022

author name string

Z. Argov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834009

5 December 2022

W. J. Bank

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834009

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1834009

5 December 2022

publication date

1 July 1991

1 reference

full work available at URL

18 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410300116

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410300116

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

5 December 2022

1 reference

18 August 2017

volume

30

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

90-97

1 reference

Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the NADH: coenzyme Q reductase inhibitor diphenyleneiodonium

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410300116

Molecular Biology and Medicine

21 January 2018

1

1

77

Taylor

1983

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

International Review of Experimental Pathology

5 December 2022

2

2

1

Radda

1985

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle

5 December 2022

3

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR.

5 December 2022

10

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Forearm metabolic asymmetry detected by 31P-NMR during submaximal exercise

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Examination of a myopathy by phosphorus nuclear magnetic resonance

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P NMR examination of two patients with NADH-CoQ reductase deficiency

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy

5 December 2022

14

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study

5 December 2022

15

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats

5 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Non-invasive Evaluation of Maliganant Hyperthermia Susceptibility with Phosphorus Nuclear Magnetic Resonance Spectroscopy

5 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy

5 December 2022

20

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Clinical use of nuclear magnetic resonance in the investigation of myopathy

5 December 2022

24

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle

5 December 2022

25

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis

5 December 2022

26

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis. An in vivo study of phosphoglycerate mutase deficiency

5 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Metabolic myopathy in canine muscle-type phosphofructokinase deficiency

5 December 2022

28

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P-NMR studies on an animal model of human defective muscle glycolysis

5 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Muscle bio-energetics in acute glycolytic block: in vivo phosphorus-nuclear magnetic resonance study of iodo-acetate injected rats

5 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy

5 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy

5 December 2022

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion

5 December 2022

33

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Contracture in McArdle's disease. Stability of adenosine triphosphate during contracture in phosphorylase-deficient human muscle

5 December 2022

35

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Iodoacetate inhibition of glyceraldehyde-3-phosphate dehydrogenase as a model of human myophosphorylase deficiency (McArdle's disease) and phosphofructokinase deficiency (Tarui's disease)

5 December 2022

36

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance

5 December 2022

39

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes

5 December 2022

41

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose

5 December 2022

42

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P-NMR studies of normal and dystrophic chicken muscle

5 December 2022

44

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

In vivo phosphorus nuclear magnetic resonance (31P-NMR) study of dystrophic hamster muscle

5 December 2022

46

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiester content of human muscle.

5 December 2022

47

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study

5 December 2022

48

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

5 December 2022

49

24

165

Gross

1988

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

In vivo P-NMR spectroscopy: muscle energy exchange in paramyotonia patients

5 December 2022

50

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance

5 December 2022

52

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure

5 December 2022

53

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Phosphorus nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in chronic alcoholics

5 December 2022

54

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Metabolic changes in human muscle denervation: topical 31P NMR spectroscopy studies

5 December 2022

55

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

The use of NMR spectroscopy for the understanding of disease

5 December 2022

56

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

5 December 2022

57

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study

5 December 2022

58

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

5 December 2022

59

18

119

Argov

1986

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study

5 December 2022

61

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

Spatial heterogeneity of metabolism in skeletal muscle in vivo studied by 31P-NMR spectroscopy

5 December 2022

63

1 reference

https://api.crossref.org/works/10.1002/ANA.410300116

5 December 2022

Identifiers

1 reference

release_5sh62owqhbh3hgxoqe7skggpau

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5sh62owqhbh3hgxoqe7skggpau

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference